Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, today announced it has acquired ExtremoChem Lda...
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership...
Hovione and Laxxon Medical announced a strategic collaboration to advance the use of 3D screen printing technologies for the pharmaceutical industry. ...
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained...
Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO Leadership Award across all six categories – capability,...
The companies certified as 2023 Top Employers have just been announced and Hovione has been recognised as Top Employer in Portugal, the United States ...
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful...
Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services....
Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the...
Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione's Chief...
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize...
Hovione, the global leader in spray drying and particle engineering announced that it is expanding its New Jersey site in East Windsor, laying the...
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world...
Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270...
Hovione, the leader in Pharmaceutical Spray Drying, today announced the launch of ASD-HIPROS, a proprietary screening service for spray dried...
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®. Captisol®, a...
Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020. Dr. Herbeaux held, over...
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of...
Hovione has issued a bond of $50 million US dollars maturing in 2033. (Logo: https://mma.prnewswire.com/media/813604/Hovione_Logo.jpg ) The bond was...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.